Chinese Nanjing University Researchers Publish 7-Year Study Results
"Young Blood Shows Effects... Research Is Just the Beginning"
Can transfusing young blood slow down aging? Chinese researchers have attracted attention by confirming the anti-aging effects of "young blood transfusion" in experiments using mice.
Researchers from the Department of Biotechnology at Nanjing University in China recently announced that after conducting transfusion experiments on hundreds of mice over the past seven years, they observed extended lifespans and slowed aging. These research results were published in the latest issue of the international academic journal Nature Ageing.
American billionaire Brian Johnson conducting an experiment to slow down aging by transfusing his body with the blood of his 17-year-old son [Image source=Instagram capture]
The research team extracted so-called "anti-aging substances" from the blood of young male mice about 20 months old and injected them weekly into the experimental mice to observe changes. The average lifespan of laboratory mice is generally 840 days. However, the mice in this experiment survived an average of 1,031 days, showing a 22.7% increase in lifespan. This indicates that the anti-aging substances achieved a certain level of success.
In particular, the longest-living experimental mouse lived for 1,266 days, which the researchers explained is equivalent to living 120 to 130 years in human terms. Additionally, the team noted, "We also observed slowed aging in the internal organs, bones, and other parts of the experimental mice."
Dr. Zhang Tianyu from Nanjing University, who led the study, told the Hong Kong media outlet South China Morning Post (SCMP), "We accumulated data from hundreds of mice over seven years to reveal the effects of 'young blood.' This research is just the beginning, and there is much more to uncover."
The speculation that transfusing young people's blood into elderly individuals can slow aging has persisted for a long time. Recently, there have even been cases where individuals have used their own bodies as clinical trial subjects to undergo "young blood transfusions."
Brian Johnson, an American IT entrepreneur and millionaire, claimed last May that after transfusing his own plasma into his father, his father's biological age became 25 years younger. He conducted a so-called "three-generation transfusion experiment," injecting his 17-year-old son's blood into himself and transfusing his own blood into his father, attracting worldwide attention.
He meticulously documented the experiment process on his personal blog. In a post written last November, he stated, "I do not know whether the slowed aging in my father is due to the removal of his plasma or the receipt of my plasma," but added, "My father's aging rate has slowed, and more than six months later, that level has been maintained."
However, the U.S. Food and Drug Administration (FDA) warns that frequent plasma infusions can cause illnesses or increase the risk of infections, allergies, and various diseases.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
